AIM EXAM REASONING

Question:

A 60-year-old man receives a drug that causes pupillary constriction and improves drainage of aqueous humor. At the same time, his pulse falls from 78/min to 58/min. Which pair of receptors best accounts for these two effects respectively?

Correct Answer: M3 in the eye and M2 in the heart

Explanation: Ocular M3 stimulation contracts the sphincter and ciliary muscles, whereas cardiac M2 activation slows SA nodal activity.

Question:

During an experiment, stimulation of an autonomic ganglion produces rapid depolarization of the postganglionic neuron. The receptor involved differs structurally from muscarinic receptors. Which property best characterizes this ganglionic receptor?

Correct Answer: Ligand-gated ion channel receptor

Explanation: Autonomic ganglia contain neuronal nicotinic receptors, which are ligand-gated ion channels producing rapid depolarization.

Question:

A student traces sympathetic innervation to an eccrine sweat gland. The postganglionic fiber belongs to the sympathetic division, but its neurotransmitter differs from that released by most sympathetic postganglionic fibers. Which transmitter is released at this neuroeffector junction?

Correct Answer: Acetylcholine

Explanation: Sympathetic postganglionic fibers supplying eccrine sweat glands are an important cholinergic exception and release acetylcholine.

Question:

A researcher applies acetylcholine to an isolated blood vessel with intact endothelium and observes relaxation rather than contraction. Which mechanism best explains this response?

Correct Answer: M3 activation promotes endothelial nitric oxide release

Explanation: Endothelial M3 stimulation releases nitric oxide, which relaxes adjacent vascular smooth muscle and produces vasodilation.

Question:

Two choline esters are compared experimentally. Drug X is rapidly destroyed after administration, whereas Drug Y remains active because it is relatively resistant to cholinesterase. Which drug is most consistent with Drug Y?

Correct Answer: Carbachol

Explanation: Carbachol is a direct-acting choline ester relatively resistant to acetylcholinesterase, giving it a longer action than acetylcholine.

Question:

A patient receives an acetylcholinesterase inhibitor that acts mainly outside the CNS because it crosses the blood-brain barrier poorly. Which drug best fits this pharmacokinetic profile?

Correct Answer: Neostigmine

Explanation: Neostigmine is predominantly peripheral because its charged structure limits penetration across the blood-brain barrier.

Question:

A patient receives a drug that directly activates cholinergic receptors without requiring release of endogenous acetylcholine. Which drug belongs to the same pharmacological category?

Correct Answer: Bethanechol

Explanation: Bethanechol is a direct cholinergic agonist; the other listed drugs enhance endogenous acetylcholine through acetylcholinesterase inhibition.

Question:

During autonomic testing, a drug increases heart rate and accelerates AV nodal conduction without a primary muscarinic action. Activation of which receptor would best account for both changes?

Correct Answer: β1 receptor

Explanation: Cardiac β1 activation produces positive chronotropy and positive dromotropy, increasing heart rate and AV conduction.

Question:

A patient with reduced salivary secretion is given a naturally occurring cholinomimetic alkaloid that directly stimulates muscarinic receptors. Which drug is most appropriate to this description?

Correct Answer: Pilocarpine

Explanation: Pilocarpine is a naturally occurring direct muscarinic agonist that increases exocrine gland secretion, including saliva.

Question:

An experimental compound stimulates β2 receptors in bronchial and uterine smooth muscle. Which functional response would be expected at both sites?

Correct Answer: Smooth-muscle relaxation

Explanation: β2 receptors are prominent in bronchial and uterine smooth muscle, where activation produces relaxation.

Question:

A patient receives an irreversible organophosphate acetylcholinesterase inhibitor. Compared with a short-acting reversible inhibitor, which feature best explains the prolonged cholinergic effect?

Correct Answer: Slow recovery of inhibited enzyme

Explanation: Organophosphates produce strong, prolonged acetylcholinesterase inhibition, so recovery of functional enzyme is much slower than with reversible inhibitors.

Question:

A man with difficulty passing urine is being evaluated before receiving a drug that increases detrusor contraction. Examination suggests that the bladder outlet is physically obstructed. What is the main pharmacological concern?

Correct Answer: Contraction against obstruction may be harmful

Explanation: Cholinomimetics increase detrusor contraction; with mechanical obstruction, stronger contraction cannot relieve the blockage and may cause harm.

Question:

A 72-year-old woman taking a centrally acting acetylcholinesterase inhibitor for cognitive symptoms develops nausea and diarrhea. Which explanation best links the therapeutic and adverse effects of the drug?

Correct Answer: Acetylcholine increases in both central and peripheral synapses

Explanation: Centrally acting acetylcholinesterase inhibitors enhance CNS cholinergic transmission but can also increase peripheral muscarinic activity, causing gastrointestinal effects.

Question:

A drug increases acetylcholine concentration wherever the transmitter is normally released. Which site would therefore show enhanced cholinergic transmission despite belonging to the sympathetic division?

Correct Answer: Eccrine sweat glands

Explanation: Eccrine sweat glands receive sympathetic postganglionic cholinergic fibers, so acetylcholinesterase inhibition enhances acetylcholine action there.

Question:

A patient develops excessive cholinergic activity after receiving an acetylcholinesterase inhibitor. In addition to increased glandular secretion, which finding would specifically indicate involvement of nicotinic receptors at the skeletal neuromuscular junction?

Correct Answer: Muscle fasciculations

Explanation: Fasciculations reflect excessive acetylcholine action at Nₘ receptors; miosis, bradycardia, secretions and cramping are predominantly muscarinic effects.

Question:

During assessment of cardiac autonomic responses, one drug decreases the frequency of SA nodal firing but does not describe a change in myocardial force. Which term specifically describes the observed change?

Correct Answer: Negative chronotropy

Explanation: Chronotropy refers to cardiac rate; reduced SA nodal firing therefore represents negative chronotropy.

Question:

A sympathetic nerve terminal releases norepinephrine. The released transmitter then binds to a receptor on the same terminal and limits further transmitter release. How should this receptor be classified?

Correct Answer: Autoreceptor

Explanation: An autoreceptor responds to the same neurotransmitter released by its own nerve terminal and can provide negative-feedback regulation.

Question:

A 64-year-old man has marked sinus bradycardia and an AV conduction abnormality. A cholinomimetic is being considered for another indication. Which physiological action provides the strongest reason for caution?

Correct Answer: Further M2-mediated cardiac slowing

Explanation: M2 stimulation decreases SA nodal rate and AV nodal conduction, potentially worsening existing bradycardia and conduction disturbance.

Question:

A patient receives an indirect cholinomimetic and shows enhanced transmission at parasympathetic effector organs, autonomic ganglia, and skeletal neuromuscular junctions. Which property of the drug best explains this broad pattern?

Correct Answer: Prevention of endogenous acetylcholine breakdown

Explanation: Acetylcholinesterase inhibition raises acetylcholine wherever it is released, enhancing both muscarinic and nicotinic cholinergic transmission.

Question:

A 35-year-old woman with myasthenia gravis develops worsening weakness while receiving an anticholinesterase drug. She also has marked salivation, abdominal cramping, miosis, and bradycardia. Which interpretation best integrates these findings?

Correct Answer: Excessive cholinergic activity causing cholinergic crisis

Explanation: Weakness accompanied by prominent muscarinic excess strongly supports cholinergic crisis from excessive anticholinesterase activity.